Parp1 Inhibitor Eliminated Imatinib-Refractory Chronic Myeloid Leukemia Cells In Bone Marrow Microenvironment Conditions
LEUKEMIA & LYMPHOMA(2019)
摘要
Treatment with tyrosine kinase inhibitors (TKIs) results in remission and prolongation of survival, but fails to eliminate the leukemia stem cells (LSCs) responsible for disease development and pro...
更多查看译文
关键词
chronic myeloid leukemia cells,parp1 inhibitor,bone marrow,imatinib-refractory
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要